medline.ch Respirationstrakt SARS

	COVID-19 anti immunoglobulin G antibodies serum levels among health care workers post COVID -19 vaccination: A single center study. Egypt J Immunol Saad SS, Omar WH, Attia FM, El Sayed AE, Eida MM, Nemr NA. PMID: 37787771 [PubMed - in process]
	Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples. Clin Chem Lab Med Padoan A, Talli I, Cosma C, Moz S, Furlan G, Navaglia F, Marchioro L, Zaninotto M, Basso D, Plebani M. PMID: 37787733 [PubMed - as supplied by publisher]
	Diagnosing viral infections through T cell receptor sequencing of activated CD8+ T cells. J Infect Dis Vujkovic A, Ha M, de Block T, van Petersen L, Brosius I, Theunissen C, van Ierssel SH, Bartholomeus E, Adriaensen W, Vanham G, Elias G, Van Damme P, Van Tendeloo V, Beutels P, van Frankenhuijsen M, Vlieghe E, Ogunjimi B, Laukens K, Meysman P, Vercauteren K. PMID: 37787611 [PubMed - as supplied by publisher]
	Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort. J Med Virol Hollstein MM, Dierks S, Schön MP, Bergmann A, Abratis A, Eidizadeh A, Kaltenbach S, Schanz J, Groß U, Leha A, Kröger A, Andag R, Zautner AE, Fischer A, Erpenbeck L, Schnelle M. PMID: 37787583 [PubMed - in process]
	SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021. Emerg Infect Dis Kuribayashi ST, Kasamatsu A, Ikenoue C, Fukusumi M, Kamiya H, Shimada T, Tanaka T, Murakami K, McLellan RT, Sekizuka T, Kuroda M, Sunagawa T. PMID: 37787491 [PubMed - as supplied by publisher]
	Right hemi diaphragmatic eventration - A rare post SARS-COV-2 infection complication. Lung India Baby BP, Mittal N. PMID: 37787362 [PubMed]
	Management and outcome of EGFR mutant lung cancer with SARS-CoV-2 infection. J Cancer Res Ther Kolluri S, Panda SS, Panda A, Singh SK. PMID: 37787329 [PubMed]
	Successful endodontic treatment reduces serum levels of cardiovascular disease risk biomarkers-high-sensitivity C-reactive protein, asymmetric dimethylarginine, and matrix metalloprotease-2. Int Endod J Al-Abdulla N, Bakhsh A, Mannocci F, Proctor G, Moyes D, Niazi SA. PMID: 37787168 [PubMed - as supplied by publisher]
	Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in Pregnancy. J Infect Dis Monroe JM, Quach HQ, Punia S, Enninga EAL, Fedyshyn Y, Girsch JH, Fedyshyn B, Lemens M, Littlefield D, Behl S, Sintim-Aboagye E, Mejia Plazas MC, Yamaoka S, Ebihara H, Pandey A, Correia C, Ung CY, Li H, Vassallo R, Sun J, Johnson EL, Olson JE, Theel ES, Badley AD, Kennedy RB, Theiler RN, Chakraborty R. PMID: 37786979 [PubMed - as supplied by publisher]
	Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study. Br J Haematol Kevli, , Maneikis K, Juozapait, Ringelevi, Vaitek, Davainien, Dauk, Vasilevska D, Sto, Narkevi, Sivickien, Rudaitis K, Minkauskas M, Naumovas D, Beinortas T, Gri. PMID: 37786970 [PubMed - as supplied by publisher]
	Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases. Rev Esp Quimioter Segura Fábrega A, Pérez Catalán I, Gómez Alfaro I, García Muñoz S, Roig Martí C, Rodríguez Lozano N, Folgado Escudero S, Varea Villanueva M, Gascón Buj A, Torres García M, Reig Valero R, Ferrando Piqueres R, Usó Blasco J. PMID: 37786958 [PubMed - as supplied by publisher]
	Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection. Am J Physiol Lung Cell Mol Physiol Easley KF, Edenfield RC, Lott MJ, Reed RC, Das Sarma J, Mehta AJ, Staitieh BS, Lipp EK, Cho IK, Johnson SK, Jones CA, Bebin-Blackwell AG, Levy JM, Tompkins SM, Easley Th CA 4th, Koval M. PMID: 37786945 [PubMed - as supplied by publisher]
	Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse. Kidney Med Hsu CM, Weiner DE, Manley HJ, Li NC, Miskulin D, Harford A, Sanders R, Ladik V, Frament J, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, Lacson EK Jr. PMID: 37786901 [PubMed]
	Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2. bioRxiv Connor RI, Sakharkar M, Rappazzo CG, Kaku CI, Curtis NC, Shin S, Wieland-Alter WF, Weiner JA, Ackerman ME, Walker LM, Lee J, Wright PF. PMID: 37786672 [PubMed]
	Expression of concern on: A SARS-CoV-2 spike receptor binding motif peptide induces anti-spike antibodies in mice andIs recognized by COVID-19 patients. Front Immunol Frontiers Editorial Office. PMID: 37786613 [PubMed - in process]
	The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology. Ibrain Anwar MM. PMID: 37786515 [PubMed]
	Impact of informal care on the mental health of caregivers during the COVID-19 pandemic. J Public Health (Oxf) Fleitas Alfonzo L, Taouk Y, Emerson E, King T. PMID: 37786356 [PubMed - as supplied by publisher]
	Radiation Oncology Practice Changes during the COVID-19 Pandemic. Int J Radiat Oncol Biol Phys Seo A, Song H, Anakwenze CP, Ausat N, Chiao EY, Lin LL. PMID: 37785538 [PubMed - in process]
	Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease. Acta Neuropathol Commun Louise R, Manon L, Vincent E, Cyntia T, Andréanne L, Philippe B, David AB, Hébert SS, Frédéric C. PMID: 37784209 [PubMed - in process]
	Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study. BMC Infect Dis Rinaldi M, Campoli C, Gallo M, Marzolla D, Zuppiroli A, Riccardi R, Casarini M, Riccucci D, Malosso M, Bonazzetti C, Pascale R, Tazza B, Pasquini Z, Marconi L, Curti S, Giannella M, Viale P. PMID: 37784051 [PubMed - in process]

Artikel 1 - 20 / 223675

Seite 1 von 11184



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung